Geneos Wealth Management’s VanEck Uranium and Nuclear ETF NLR Stock Holding History
Bought
Maintained
Sold
Other funds holding NLR
Geneos Wealth Management's NLR Position: Q3 2026 in Review
Geneos Wealth Management reduced its VanEck Uranium and Nuclear ETF (NLR) stake by 12% in Q3 2026, selling an estimated $164K and leaving 10,973 shares worth $1.14M. The position accounts for 0.02% of the portfolio, ranked #547.
Geneos Wealth Management first reported a position in NLR in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.41M in Q4 2025. 524 funds tracked by Wall St. Rank hold NLR as of Q3 2026.
- Geneos Wealth Management held 10,973 shares of VanEck Uranium and Nuclear ETF worth $1.14M as of Q3 2026.
- Geneos Wealth Management sold 1,447 VanEck Uranium and Nuclear ETF shares in Q3 2026, an estimated $164K.
- VanEck Uranium and Nuclear ETF made up 0.02% of Geneos Wealth Management's portfolio in Q3 2026, its #547 holding.
- Geneos Wealth Management first reported a position in VanEck Uranium and Nuclear ETF in Q4 2020 and has held it in 16 quarters since.
- Geneos Wealth Management's VanEck Uranium and Nuclear ETF position peaked at $2.41M in Q4 2025.
- 524 funds tracked by Wall St. Rank held VanEck Uranium and Nuclear ETF as of Q3 2026.
Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.